Ultragenyx Pharma (RARE) Tops Q2 EPS by $1.95, Revenue Beat; Offers FY20 Crysvita Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. FDX
3. META
4. ABBV
5. SPY
6. BLZE
7. IBM
8. NKE
9. MU
10. ACN

Go back to Ultragenyx Pharma (RARE) Tops Q2 EPS by $1.95, Revenue Beat; Offers FY20 Crysvita Outlook

Ultragenyx Pharma (RARE) PT Raised to $96 at Jefferies, Following Model Update Ahead Of Earnings

July 29, 2020 1:14 PM EDT

Jefferies analyst Maury Raycroft raised the price target on Ultragenyx Pharma (NASDAQ: RARE) to $96.00 (from $94.00) while maintaining a Buy rating.

... More